Publications by authors named "Guosong Luo"

Claim this Profile
C
Comparative outcomes of stereotactic body radiotherapy versus radiofrequency ablation in hepatocellular carcinoma within Milan criteria: a systematic review and meta-analysis.
Jianxiong Jing, Furui Zhong, Hao Zhang, Guosong Luo, Zongzhi Du

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of enhanced recovery after surgery protocol on liver transplantation: A meta-analysis.
Ying-Jun Zheng, Yi Pan, Dong-Lun Li, Jin-Chang Zhang, Ji-Lin Tao, Guo-Song Luo

World J Gastrointest Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Super-stable homogeneous iodinated formulation technology for improving the therapeutic effect of patients with advanced hepatocellular carcinoma.
Pan He, Furui Zhong, Bin Luo, Guosong Luo, Xuewen Wang

Quant Imaging Med Surg· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis.
Penggao Dai, Yancheng He, Guosong Luo, Jiaqi Deng, Nan Jiang

J Cell Biochem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in activating transcription factor 4 promotes carbon tetrachloride and lipopolysaccharide/D‑galactosamine‑mediated liver injury in mice.
Xiaofang Zhao, Hong Zhou, Ying Cheng, Wenjing Yu, Guosong Luo

Mol Med Rep· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage.
Wenjing Yu, Yuancai Xiang, Guosong Luo, Xiaofang Zhao, Bin Xiao

Cancer Biother Radiopharm· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt/mTOR-independent pathway.
Xiaofang Zhao, Guosong Luo, Ying Cheng, Wenjing Yu, Run Chen

J Cell Biochem· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c‑Myc promotes cholangiocarcinoma cells to overcome contact inhibition via the mTOR pathway.
Guosong Luo, Bin Li, Chunyan Duan, Ying Cheng, Bin Xiao

Oncol Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis